The risk to human islet cell transplant recipients of acquiring variant creutzfeldt-jakob disease: A provisional quantitative risk assessment

Transplantation

Volumn 92, Issue 1, 2011, Pages

  Elsaadany, Susie ^a   Tyshenko, Michael G ^b   Oraby, Tamer ^b   Malcolm, Andrew J ^c   Senior, Peter ^c   Shapiro, A M James ^c   Catford, Angela ^a   Salem, Tarek ^b,d   Wu, Jun ^a   Krewski, Daniel ^b   Rohwer, Robert G ^e,f  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d HEALTH CANADA   (Canada)

^e BALTIMORE VA MEDICAL CENTER   (United States)

^f Rohwer Technical Counseling   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SPONGIFORM ENCEPHALOPATHY; BOVINE SPONGIFORM ENCEPHALOPATHY AGENT; HUMAN; LETTER; MONTE CARLO METHOD; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; VARIANT CREUTZFELDT JAKOB DISEASE;

ANIMALS; CATTLE; CELL SEPARATION; CLOSTRIDIUM HISTOLYTICUM; CREUTZFELDT-JAKOB SYNDROME; CULTURE MEDIA; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICROBIAL COLLAGENASE; MODELS, STATISTICAL; MONTE CARLO METHOD; RISK ASSESSMENT;

EID: 79959637031     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821eabab     Document Type: Letter

References (7)

1. Harlan DM, Kenyon NS, Korsgren O, et al. Current advances and travails in islet transplantation. Diabetes 2009; 58: 2175.
2. Ballinger WF, Lacy PE. Transplantation of intact pancreatic islets in rats. Surgery 1972; 72: 175.
3. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994; 343: 950.
4. Gaglia JL, Shapiro AM, Weir GC. Islet transplantation: Progress and challenge. Arch Med Res 2005; 36: 273.
5. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363.
6. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498.
7. ElSaadany S, Giulivi A. A vCJD riskassessment case study: A preliminary quantitative assessment of Canadian vaccines incorporating bovine biological materials in their manufacture. BioProcess Int 2005; 3: 62.